Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression

Table 3 Top-ranked results of cumulative ROC in predicting breast cancer progression^a.

Cumulative top-ranked factors	Factors	Cumulative AUC	95% CI
2	HT and tissue visfatin	0.764	0.64–0.89
3	Above factors plus LN metastasis	0.827	0.73–0.93
4	Above factors plus stage	0.854	0.77–0.93
5	Above factors plus age	0.886	0.82–0.95
6	Above factors plus tumor size	0.886	0.82–0.95
7	Above factors plus ER	0.880	0.81–0.95
8	Above factors plus PR	0.863	0.78–0.94
9	Above factors plus BMI	0.861	0.77–0.95
10	Above factors plus HER2	0.863	0.78–0.95
11	Above factors plus RT	0.858	0.77–0.94
12	Above factors plus Grade	0.847	0.76–0.93
13	Above factors plus CT	0.841	0.76–0.93

Abbreviations: See Table 1
^aProgressed patients including patients with breast cancer recurrence or patients expired during 5-year follow-up

ISSN: 1475-2867